VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease
Launched by UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST · Aug 17, 2017
Trial Information
Current as of May 20, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants being given vedolizumab as part of routine care, and vedo naïve prior to study
- • Age 18 or over
- • Written informed consent obtained from patient for participation in the UK IBD Registry
- Exclusion Criteria:
- • Patient unwilling to take part in the UK IBD Registry
- • Unable to obtain written informed consent
- • Patient is, in the opinion of the investigator, not suitable to participate in the study
- • Patients with contraindications to the use of vedolizumab
About University Hospital Southampton Nhs Foundation Trust
University Hospital Southampton NHS Foundation Trust is a leading academic medical center located in the UK, renowned for its commitment to innovative healthcare and research. As a prominent sponsor of clinical trials, the Trust integrates cutting-edge research with clinical practice to advance medical knowledge and improve patient outcomes. With a diverse range of specialties, including cardiology, oncology, and pediatrics, the Trust actively collaborates with academic institutions and industry partners to conduct high-quality trials that adhere to rigorous ethical standards and regulatory guidelines. Its multidisciplinary approach ensures comprehensive patient care while fostering an environment of scientific inquiry and discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barnsley, South Yorkshire, United Kingdom
Brighton, East Sussex, United Kingdom
Exeter, Devon, United Kingdom
London, Greater London, United Kingdom
Southampton, Hampshire, United Kingdom
Truro, Cornwall, United Kingdom
Sheffield, South Yorkshire, United Kingdom
Newcastle Upon Tyne, Tyne And Wear, United Kingdom
Wolverhampton, West Midlands, United Kingdom
London, Greater London, United Kingdom
York, North Yorkshire, United Kingdom
Watford, Hertfordshire, United Kingdom
Liverpool, Merseyside, United Kingdom
Kingston, Greater London, United Kingdom
London, Greater London, United Kingdom
London, Greater London, United Kingdom
London, Greater London, United Kingdom
Maidstone, Kent, United Kingdom
Grantham, Lincolnshire, United Kingdom
Shrewsbury, Shropshire, United Kingdom
Bury Saint Edmunds, Suffolk, United Kingdom
Huddersfield, West Yorkshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials